PRE-REQUISITES: Current PT, PTA, OT, OTA, SLP, MD, DO, DPM, PA, NP, RN license.
On Sale $998!
Course Dates: Sept 14 & 15, 2024 - via Live Teletraining , No Travel Required! Total Contact Hours: 17.5 CEUs
Specialty Rehab and ILWT have partnered in this specially designed course for clinicians with a CLT or CLWT certification: Oncology for the Lymphedema Specialist. There are over 17 million people who live with or have a history of cancer, this number is expected to increase to over 26 million by 2040. Cancer survival is growing, and cancer is becoming a chronic condition. To effectively treat oncology lymphedema patients, we must have knowledge of cancer, treatment, and its side effects. These side effects impact the oncology population you are presently and will continue treating.
This course is packed with evidence-based research on the anatomy and physiology of the lymphatic system, surgical interventions, and wound care specifics for cancer patients. Training will include an overview of high-risk lymphedema oncology populations followed by a deep dive into breast cancer diagnosis, treatment, and rehabilitation. The course will include treatment for: axillary webbing syndrome, breast lymphedema, and post-mastectomy pain syndrome, and labs.
Total Contact Hours: 17.5
Twenty-six million individuals will be living with a history of cancer by 2040. With increases in early detection and advances in treatments, individuals with cancer are living longer. The need for improved side-effect management and focus on quality of life is becoming more imperative. The prevalence of lymphedema due to cancer and its treatment varies throughout the literature depending on diagnostic and inclusion criteria, measurement techniques, and follow-up time, with estimates greater than 70% for some cancer types. The impact of lymphedema on the cancer survivor is unique to each cancer experience. To design an effective treatment plan and goals for an individual with cancer-related lymphedema (CRL) the impact of cancer and its treatment must be accounted for. Self-paced online modules will provide a foundation for understanding the cancer experience including typical medical treatments and the physical, emotional, and psychosocial impairments that limit participation and quality of life throughout the survivorship continuum. Live- online didactic material will provide a knowledge of current medical treatments, side effects and rehabilitation management in high-risk populations for developing CRL as well as the latest advances in medical treatment and prevention of cancer-related lymphedema. In addition, lab components will review treatment techniques for high-risk lymphedema populations and engage the learner in application of clinical reasoning through live case studies.
Advanced Education. Specialized training for licensed health care professionals.
Best suited for licensed rehabilitation specialists who work with individuals with cancer and lymphedema.
Target Audience: Rehabilitationprofessionals with CLT or CLWT certification. (OT, COTA, PT, PTA, SLP, RN)
The course is offered as an instructor led course with both lecture and lab components. Course materials are provided in the form of live teletraining / remote learning with an instructor that is a subject matter expert within the field covered. The in-person lecture and lab format allows for an interactive learning environment which fosters the development of appropriate reasoning and problem solving skills combined with refinement of manual skills specific to the oncology population. Participants may be given a final written exam at the end of the course as well as a lab competency exam to assess both manual and clinical reasoning skills.
Successful completion of the course, as demonstrated by >70% on the written exam and a passing score on the lab competency will result in provision of specialist certification and credit for continuing education hours. Participants not receiving >70% the written exam and failing the lab competency will not receive specialist certification; however will receive course credit for continuing education hours.
*Should you have special needs requests to successfully complete your training, please contact us.
Lisa Marshall, OTR/L, CLWT is Founder & CEO, Specialty Rehabilitation Oncology Consulting & Education, Director of Oncology Education, ILWTI
With nearly three decades of rehabilitation experience across multiple settings, Lisa Marshall has specialized in oncology rehabilitation most of her professional life. In 2002, she founded Specialty Rehabilitation Inc. (SRI)—an outpatient therapy clinic providing distinctly specialized physical and occupational therapy services in oncology rehabilitation through palliation programs, including but not limited to: breast, head and neck, gynecological, prostate, lung, central nervous system, and blood cancers. SRI also provided treatment programs for cancer-related fatigue, chemotherapy-induced peripheral neuropathy, cancer-related cognitive impairments (also known as chemo brain), and more.
In addition to providing patient care, Lisa has been educating healthcare professionals since 2003. In 2016, she expanded her reach as an educator and cancer rehabilitation program consultant for major cancer centers, outpatient providers, skilled nursing providers, home healthcare agencies, and private practices. In 2021, SRI rolled out a comprehensive menu of online education and training programs for healthcare professionals, patients, and caregivers.
Lisa is also a certified lymphedema and wound therapist (CLWT). She is well known nationally for developing and teaching the Certified Oncology Rehabilitation Expert (CORE) certification program and has served as Director of Oncology Education at the International Lymphedema and
Wound Training Institute (ILWTI) since 2018. In 2021, the American Occupational Therapy Association honored Lisa with the Recognition of Achievement Award for Exemplary Contribution to Oncology and Lymphedema Rehabilitation.
Please note that the email entered when checking out will be used to send you important course information. Use a personal email vs work email. Work emails have firewalls which may prevent ILWTI emails from reaching you.